• 
  2024/10/30

  To announce the expected date of the board of directors meeting to approve the consolidated financial statements for the third

• 
  2024/10/1

  Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD.,regarding acquisition of right-of-use asset from a relat

• 
  2024/9/24

  Announced that the cumulative disposition of securities has reached the announcement standard.

• 
  2024/9/13

  TSH Biopharm was invited to attend the online institutional investor conference hosted by Reliance Securities

• 
  2024/8/14

  Correct_Announced that the cumulative disposition of securities has reached the announcement standard.

• 
  2024/8/7

  TSH Board of Directors of the Company agreed to assign members of remuneration committee

• 
  2024/8/7

  TSH Board of Directors Approved the Consolidated Financial Statements For the Six Months Ended June 30, 2024

• 
  2024/7/30

  To announce the expected date of the board of directors meeting to approve the consolidated financial statements for the second

• 
  2024/6/28

  Announcement on behalf of major subsidiary,TOP PHARM. MEDICALWARE COMPANY LIMITED,regarding the important resolutions of 2024 A

• 
  2024/6/28

  Announcement on behalf of major subsidiary,TOP PHARM. MEDICALWARE COMPANY LIMITED,regarding the important resolutions of 2024 A